|
1
|
International Agency for Research on
Cancer: GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and
Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.asp.
|
|
2
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar
|
|
3
|
Meltzer PS: Cancer genomics: Small RNAs
with big impacts. Nature. 435:745–746. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–D73. 2014. View Article : Google Scholar :
|
|
5
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S, et al: The nuclear RNase III
Drosha initiates microRNA processing. Nature. 425:415–419. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yi R, Qin Y, Macara IG and Cullen BR:
Exportin-5 mediates the nuclear export of pre-microRNAs and short
hairpin RNAs. Genes Dev. 17:3011–3016. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar
|
|
9
|
Zhang H, Kolb FA, Brondani V, Billy E and
Filipowicz W: Human Dicer preferentially cleaves dsRNAs at their
termini without a requirement for ATP. EMBO J. 21:5875–5885. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ørom UA, Nielsen FC and Lund AH:
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and
enhances their translation. Mol Cell. 30:460–471. 2008. View Article : Google Scholar
|
|
13
|
Tay Y, Zhang J, Thomson AM, Lim B and
Rigoutsos I: MicroRNAs to Nanog, Oct4 and Sox2 coding regions
modulate embryonic stem cell differentiation. Nature.
455:1124–1128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chivukula RR and Mendell JT: Circular
reasoning: microRNAs and cell-cycle control. Trends Biochem Sci.
33:474–481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lynam-Lennon N, Maher SG and Reynolds JV:
The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos
Soc. 84:55–71. 2009. View Article : Google Scholar
|
|
18
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Zhang Y, Zhang Y, Ding J, Wu K and
Fan D: Survival prediction of gastric cancer by a seven-microRNA
signature. Gut. 59:579–585. 2010. View Article : Google Scholar
|
|
20
|
Chen Z, Saad R, Jia P, Peng D, Zhu S,
Washington MK, Zhao Z, Xu Z and El-Rifai W: Gastric adenocarcinoma
has a unique microRNA signature not present in esophageal
adenocarcinoma. Cancer. 119:1985–1993. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moreira FC, Assumpção M, Hamoy IG, Darnet
S, Burbano R, Khayat A, Gonçalves AN, Alencar DO, Cruz A, Magalhães
L, et al: MiRNA expression profile for the human gastric antrum
region using ultra-deep sequencing. PLoS One. 9:e923002014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar
|
|
23
|
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang
C, Huang D, Chen X, Zhang H, Zhuang R, et al: A five-microRNA
signature identified from genome-wide serum microRNA expression
profiling serves as a fingerprint for gastric cancer diagnosis. Eur
J Cancer. 47:784–791. 2011. View Article : Google Scholar
|
|
24
|
Zhou X, Zhu W, Li H, Wen W, Cheng W, Wang
F, Wu Y, Qi L, Fan Y, Chen Y, et al: Diagnostic value of a plasma
microRNA signature in gastric cancer: A microRNA expression
analysis. Sci Rep. 5:112512015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lo SS, Hung PS, Chen JH, Tu HF, Fang WL,
Chen CY, Chen WT, Gong NR and Wu CW: Overexpression of miR-370 and
downregulation of its novel target TGFβ-RII contribute to the
progression of gastric carcinoma. Oncogene. 31:226–237. 2012.
View Article : Google Scholar
|
|
26
|
Kim CH, Kim HK, Rettig RL, Kim J, Lee ET,
Aprelikova O, Choi IJ, Munroe DJ and Green JE: miRNA signature
associated with outcome of gastric cancer patients following
chemotherapy. BMC Med Genomics. 4:792011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang
Z, Chen F and Zheng G: Identification of hsa-miR-335 as a
prognostic signature in gastric cancer. PLoS One. 7:e400372012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu BQ, Su LP, Li JF, Cai Q, Yan M, Chen
XH, Yu YY, Gu QL, Zhu ZG and Liu BY: microrna expression signature
of gastric cancer cells relative to normal gastric mucosa. Mol Med
Rep. 6:821–826. 2012.PubMed/NCBI
|
|
29
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Darnet S, Moreira FC, Hamoy IG, Burbano R,
Khayat A, Cruz A, Magalhães L, Silva A, Santos S, Demachki S, et
al: High-throughput sequencing of miRNAs reveals a tissue signature
in gastric cancer and suggests novel potential biomarkers.
Bioinform Biol Insights. 9(Suppl 1): 1–8. 2015.PubMed/NCBI
|
|
31
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu G, Qin XQ, Guo JJ, Li TY and Chen JH:
AKT/ERK activation is associated with gastric cancer cell
resistance to paclitaxel. Int J Clin Exp Pathol. 7:1449–1458.
2014.PubMed/NCBI
|
|
33
|
Pennarun B, Meijer A, de Vries EG,
Kleibeuker JH, Kruyt F and de Jong S: Playing the DISC: Turning on
TRAIL death receptor-mediated apoptosis in cancer. Biochim Biophys
Acta. 1805:123–140. 2010.
|
|
34
|
Tchernitsa O, Kasajima A, Schäfer R, Kuban
RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W, Ebert
MP, et al: Systematic evaluation of the miRNA-ome and its
downstream effects on mRNA expression identifies gastric cancer
progression. J Pathol. 222:310–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sempere LF, Freemantle S, Pitha-Rowe I,
Moss E, Dmitrovsky E and Ambros V: Expression profiling of
mammalian microRNAs uncovers a subset of brain-expressed microRNAs
with possible roles in murine and human neuronal differentiation.
Genome Biol. 5:R132004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nohata N, Hanazawa T, Enokida H and Seki
N: microRNA-1/133a and microRNA-206/133b clusters: Dysregulation
and functional roles in human cancers. Oncotarget. 3:9–21.
2012.PubMed/NCBI
|
|
37
|
Mitchelson KR and Qin WY: Roles of the
canonical myomiRs miR-1, -133 and -206 in cell development and
disease. World J Biol Chem. 6:162–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hilmarsdottir B, Briem E, Bergthorsson JT,
Magnusson MK and Gudjonsson T: Functional Role of the microRNA-200
Family in Breast Morphogenesis and Neoplasia. Genes (Basel).
5:804–820. 2014.
|
|
39
|
Mataki H, Enokida H, Chiyomaru T, Mizuno
K, Matsushita R, Goto Y, Nishikawa R, Higashimoto I, Samukawa T,
Nakagawa M, et al: Downregulation of the microRNA-1/133a cluster
enhances cancer cell migration and invasion in lung-squamous cell
carcinoma via regulation of Coronin1C. J Hum Genet. 60:53–61. 2015.
View Article : Google Scholar
|
|
40
|
Liu L, Shao X, Gao W, Zhang Z, Liu P, Wang
R, Huang P, Yin Y and Shu Y: MicroRNA-133b inhibits the growth of
non-small-cell lung cancer by targeting the epidermal growth factor
receptor. FEBS J. 279:3800–3812. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun C, Liu Z, Li S, Yang C, Xue R, Xi Y,
Wang L, Wang S, He Q, Huang J, et al: Down-regulation of c-Met and
Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell
proliferation, migration and colony formation. Oncotarget.
6:25533–25574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Beltran AS, Russo A, Lara H, Fan C,
Lizardi PM and Blancafort P: Suppression of breast tumor growth and
metastasis by an engineered transcription factor. PLoS One.
6:e245952011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ge X, Lyu P, Cao Z, Li J, Guo G, Xia W and
Gu Y: Overexpression of miR-206 suppresses glycolysis,
proliferation and migration in breast cancer cells via PFKFB3
targeting. Biochem Biophys Res Commun. 463:1115–1121. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chang YS, Chen WY, Yin JJ,
Sheppard-Tillman H, Huang J and Liu YN: EGF receptor promotes
prostate cancer bone metastasis by downregulating miR-1 and
activating TWIST1. Cancer Res. 75:3077–3086. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kojima S, Chiyomaru T, Kawakami K, Yoshino
H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M, et
al: Tumour suppressors miR-1 and miR-133a target the oncogenic
function of purine nucleoside phosphorylase (PNP) in prostate
cancer. Br J Cancer. 106:405–413. 2012. View Article : Google Scholar :
|
|
46
|
Tao J, Wu D, Xu B, Qian W, Li P, Lu Q, Yin
C and Zhang W: microRNA-133 inhibits cell proliferation, migration
and invasion in prostate cancer cells by targeting the epidermal
growth factor receptor. Oncol Rep. 27:1967–1975. 2012.PubMed/NCBI
|
|
47
|
Xu L, Zhang Y, Wang H, Zhang G, Ding Y and
Zhao L: Tumor suppressor miR-1 restrains epithelial-mesenchymal
transition and metastasis of colorectal carcinoma via the MAPK and
PI3K/AKT pathway. J Transl Med. 12:2442014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Oberg AL, French AJ, Sarver AL,
Subramanian S, Morlan BW, Riska SM, Borralho PM, Cunningham JM,
Boardman LA, Wang L, et al: miRNA expression in colon polyps
provides evidence for a multihit model of colon cancer. PLoS One.
6:e204652011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Du YY, Zhao LM, Chen L, Sang MX, Li J, Ma
M and Liu JF: The tumor-suppressive function of miR-1 by targeting
LASP1 and TAGLN2 in esophageal squamous cell carcinoma. J
Gastroenterol Hepatol. 31:384–393. 2016. View Article : Google Scholar
|
|
50
|
Fu HL, Wu P, Wang XF, Wang JG, Jiao F,
Song LL, Xie H, Wen XY, Shan HS, Du YX, et al: Altered miRNA
expression is associated with differentiation, invasion, and
metastasis of esophageal squamous cell carcinoma (ESCC) in patients
from Huaian, China. Cell Biochem Biophys. 67:657–668. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y
and Zheng X: MicroRNA-1 and microRNA-499 downregulate the
expression of the ets1 proto-oncogene in HepG2 cells. Oncol Rep.
28:701–706. 2012.PubMed/NCBI
|
|
52
|
Tsai KW, Hu LY, Chen TW, Li SC, Ho MR, Yu
SY, Tu YT, Chen WS and Lam HC: Emerging role of microRNAs in
modulating endothelin-1 expression in gastric cancer. Oncol Rep.
33:485–493. 2015.
|
|
53
|
Han C, Zhou Y, An Q, Li F, Li D, Zhang X,
Yu Z, Zheng L, Duan Z and Kan Q: MicroRNA-1 (miR-1) inhibits
gastric cancer cell proliferation and migration by targeting MET.
Tumour Biol. 36:6715–6723. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lin YH, Park ZY, Lin D, Brahmbhatt AA, Rio
MC, Yates JR III and Klemke RL: Regulation of cell migration and
survival by focal adhesion targeting of Lasp-1. J Cell Biol.
165:421–432. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang Q, Zhang C, Huang B, Li H, Zhang R,
Huang Y and Wang J: Downregulation of microRNA-206 is a potent
prognostic marker for patients with gastric cancer. Eur J
Gastroenterol Hepatol. 25:953–957. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ren J, Huang HJ, Gong Y, Yue S, Tang LM
and Cheng SY: MicroRNA-206 suppresses gastric cancer cell growth
and metastasis. Cell Biosci. 4:262014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang L, Xia L, Zhao L, Chen Z, Shang X,
Xin J, Liu M, Guo X, Wu K, Pan Y, et al: Activation of PAX3-MET
pathways due to miR-206 loss promotes gastric cancer metastasis.
Carcinogenesis. 36:390–399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shi H, Han J, Yue S, Zhang T, Zhu W and
Zhang D: Prognostic significance of combined microRNA-206 and
CyclinD2 in gastric cancer patients after curative surgery: A
retrospective cohort study. Biomed Pharmacother. 71:210–215. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang XT, Zhang Z, Xin YN, Ma XZ and Xuan
SY: Impairment of growth of gastric carcinoma by miR-133-mediated
Her-2 inhibition. Tumour Biol. 36:8925–8930. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liu Y, Zhang X, Zhang Y, Hu Z, Yang D,
Wang C, Guo M and Cai Q: Identification of miRNomes in human
stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic
target for gastric cancer. Cancer Lett. 369:58–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cheng Z, Liu F, Wang G, Li Y, Zhang H and
Li F: miR-133 is a key negative regulator of CDC42-PAK pathway in
gastric cancer. Cell Signal. 26:2667–2673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Rechavi O, Erlich Y, Amram H, Flomenblit
L, Karginov FV, Goldstein I, Hannon GJ and Kloog Y: Cell
contact-dependent acquisition of cellular and viral nonautonomously
encoded small RNAs. Genes Dev. 23:1971–1979. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chitwood DH and Timmermans MC: Small RNAs
are on the move. Nature. 467:415–419. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zen K and Zhang CY: Circulating microRNAs:
A novel class of biomarkers to diagnose and monitor human cancers.
Med Res Rev. 32:326–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z,
Wang JF, Zhang Z, Lu S, Huang X, et al: Plasma microRNA panel to
diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin
Oncol. 29:4781–4788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Schultz NA, Dehlendorff C, Jensen BV,
Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE,
Yilmaz M, Holländer NH, et al: MicroRNA biomarkers in whole blood
for detection of pancreatic cancer. JAMA. 311:392–404. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of
microRNAs in plasma of patients with colorectal cancer: A potential
marker for colorectal cancer screening. Gut. 58:1375–1381. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhu C, Ren C, Han J, Ding Y, Du J, Dai N,
Dai J, Ma H, Hu Z, Shen H, et al: A five-microRNA panel in plasma
was identified as potential biomarker for early detection of
gastric cancer. Br J Cancer. 110:2291–2299. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhu X, Lv M, Wang H and Guan W:
Identification of circulating microRNAs as novel potential
biomarkers for gastric cancer detection: A systematic review and
meta-analysis. Dig Dis Sci. 59:911–919. 2014. View Article : Google Scholar
|
|
72
|
Huang D, Wang H, Liu R, Li H, Ge S, Bai M,
Deng T, Yao G and Ba Y: miRNA27a is a biomarker for predicting
chemosensitivity and prognosis in metastatic or recurrent gastric
cancer. J Cell Biochem. 115:549–556. 2014. View Article : Google Scholar
|
|
73
|
Cai H, Yuan Y, Hao YF, Guo TK, Wei X and
Zhang YM: Plasma microRNAs serve as novel potential biomarkers for
early detection of gastric cancer. Med Oncol. 30:4522013.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Liu N, Williams AH, Kim Y, McAnally J,
Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R and
Olson EN: An intragenic MEF2-dependent enhancer directs
muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad
Sci USA. 104:20844–20849. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Gómez-Benito M, Conchillo A, García MA,
Vázquez I, Maicas M, Vicente C, Cristobal I, Marcotegui N,
García-Ortí L, Bandrés E, et al: EVI1 controls proliferation in
acute myeloid leukaemia through modulation of miR-1–2. Br J Cancer.
103:1292–1296. 2010. View Article : Google Scholar
|
|
76
|
Sharma SB, Lin CC, Farrugia MK, McLaughlin
SL, Ellis EJ, Brundage KM, Salkeni MA and Ruppert JM: MicroRNAs 206
and 21 cooperate to promote RAS-extracellular signal-regulated
kinase signaling by suppressing the translation of RASA1 and
SPRED1. Mol Cell Biol. 34:4143–4164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Adams BD, Claffey KP and White BA:
Argonaute-2 expression is regulated by epidermal growth factor
receptor and mitogen-activated protein kinase signaling and
correlates with a transformed phenotype in breast cancer cells.
Endocrinology. 150:14–23. 2009. View Article : Google Scholar :
|
|
78
|
Rao PK, Kumar RM, Farkhondeh M,
Baskerville S and Lodish HF: Myogenic factors that regulate
expression of muscle-specific microRNAs. Proc Natl Acad Sci USA.
103:8721–8726. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Tan SB, Li J, Chen X, Zhang W, Zhang D,
Zhang C, Li D and Zhang Y: Small molecule inhibitor of myogenic
microRNAs leads to a discovery of miR-221/222-myoD-myomiRs
regulatory pathway. Chem Biol. 21:1265–1270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Mallappa C, Hu YJ, Shamulailatpam P, Tae
S, Sif S and Imbalzano AN: The expression of myogenic microRNAs
indirectly requires protein arginine methyltransferase (Prmt)5 but
directly requires Prmt4. Nucleic Acids Res. 39:1243–1255. 2011.
View Article : Google Scholar :
|
|
81
|
Kozakowska M, Ciesla M, Stefanska A,
Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J,
Szymula A, Bartelik A, et al: Heme oxygenase-1 inhibits myoblast
differentiation by targeting myomirs. Antioxid Redox Signal.
16:113–127. 2012. View Article : Google Scholar :
|
|
82
|
Singh A, Happel C, Manna SK,
Acquaah-Mensah G, Carrerero J, Kumar S, Nasipuri P, Krausz KW,
Wakabayashi N, Dewi R, et al: Transcription factor NRF2 regulates
miR-1 and miR-206 to drive tumorigenesis. J Clin Invest.
123:2921–2934. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Sun Y, Ge Y, Drnevich J, Zhao Y, Band M
and Chen J: Mammalian target of rapamycin regulates miRNA-1 and
follistatin in skeletal myogenesis. J Cell Biol. 189:1157–1169.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Feng Y, Niu LL, Wei W, Zhang WY, Li XY,
Cao JH and Zhao SH: A feedback circuit between miR-133 and the
ERK1/2 pathway involving an exquisite mechanism for regulating
myoblast proliferation and differentiation. Cell Death Dis.
4:e9342013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Datta J, Kutay H, Nasser MW, Nuovo GJ,
Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, et
al: Methylation mediated silencing of MicroRNA-1 gene and its role
in hepato-cellular carcinogenesis. Cancer Res. 68:5049–5058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chen WS, Leung CM, Pan HW, Hu LY, Li SC,
Ho MR and Tsai KW: Silencing of miR-1-1 and miR-133a-2 cluster
expression by DNA hypermethylation in colorectal cancer. Oncol Rep.
28:1069–1076. 2012.PubMed/NCBI
|
|
87
|
Winbanks CE, Beyer C, Hagg A, Qian H,
Sepulveda PV and Gregorevic P: miR-206 represses hypertrophy of
myogenic cells but not muscle fibers via inhibition of HDAC4. PLoS
One. 8:e735892013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wade PA: Transcriptional control at
regulatory checkpoints by histone deacetylases: Molecular
connections between cancer and chromatin. Hum Mol Genet.
10:693–698. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Gagan J, Dey BK, Layer R, Yan Z and Dutta
A: Notch3 and Mef2c proteins are mutually antagonistic via Mkp1
protein and miR-1/206 microRNAs in differentiating myoblasts. J
Biol Chem. 287:40360–40370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Furukawa S, Kawasaki Y, Miyamoto M,
Hiyoshi M, Kitayama J and Akiyama T: The miR-1-NOTCH3-Asef pathway
is important for colorectal tumor cell migration. PLoS One.
8:e806092013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Nasser MW, Datta J, Nuovo G, Kutay H,
Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K:
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Hudson RS, Yi M, Esposito D, Watkins SK,
Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB,
et al: MicroRNA-1 is a candidate tumor suppressor and prognostic
marker in human prostate cancer. Nucleic Acids Res. 40:3689–3703.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Alexiou P, Maragkakis M, Papadopoulos GL,
Reczko M and Hatzigeorgiou AG: Lost in translation: An assessment
and perspective for computational microRNA target identification.
Bioinformatics. 25:3049–3055. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Hsu SD, Tseng YT, Shrestha S, Lin YL,
Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, et al:
miRTarBase update 2014: An information resource for experimentally
validated miRNA-target interactions. Nucleic Acids Res. 42:D78–D85.
2014. View Article : Google Scholar :
|
|
95
|
Zheng Z, Yan D, Chen X, Huang H, Chen K,
Li G, Zhou L, Zheng D, Tu L and Dong XD: MicroRNA-206: Effective
Inhibition of Gastric Cancer Progression through the c-Met Pathway.
PLoS One. 10:e01287512015. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Yan D, Dong XE, Chen X, Wang L, Lu C, Wang
J, Qu J and Tu L: MicroRNA-1/206 targets c-Met and inhibits
rhabdo-myosarcoma development. J Biol Chem. 284:29596–29604. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhang L, Liu X, Jin H, Guo X, Xia L, Chen
Z, Bai M, Liu J, Shang X, Wu K, et al: miR-206 inhibits gastric
cancer proliferation in part by repressing cyclinD2. Cancer Lett.
332:94–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
